Shuli Tang

561 citations
18 papers · 281 indexed · h-index 9
Topics
Extracellular vesicles in disease (3 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)Genetic factors in colorectal cancer (3 papers)
Journals
SHILAP Revista de lepidopterologíaAnalytical ChemistryJournal of Cellular Physiology

In The Last Decade

Shuli Tang

16 papers receiving 280 citations

Peers

Shuli Tang
Comparison fields: 5 of 52
  • Cancer Research 171
  • Molecular Biology 162
  • Oncology 81
  • Pulmonary and Respiratory Medicine 46
  • Surgery 34
Replace Yoriko Takahashi with:
Yoriko Takahashi Japan
Zhixiang Jian China
Qunxiong Pan China
Yifei Ma China
Runkun Yang China
Maosong Lin China
Αναστασία Κατσιαμπούρα United States
Sofía del Carmen Spain
Jacob S. Ankeny United States
Zorka Inić Serbia
Shuli Tang relative to Yoriko Takahashi Japan Yoriko Takahashi's profile →
Citations per field
00.5×1.5×2.4×
Yoriko Takahashi · 1×
Citations per year

Countries citing papers authored by Shuli Tang

Since Specialization
Citations

This map shows the geographic impact of Shuli Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuli Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuli Tang more than expected).

Fields of papers citing papers by Shuli Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuli Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuli Tang. The network helps show where Shuli Tang may publish in the future.

Co-authorship network of co-authors of Shuli Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuli Tang. A scholar is included among the top collaborators of Shuli Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuli Tang. Shuli Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 2
5 4
6 3
7 1
8 2
9 23
10 16
11 12
12 8
13 22
14 56
15 50
16 8
17 26
18 46

About Shuli Tang

Shuli Tang is a scholar working on Cancer Research, Hepatology and Oncology, having authored 18 papers that have together received 281 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Genetic factors in colorectal cancer (3 papers). The work is most often cited by research in Cancer Research (171 citations), Oncology (81 citations) and Molecular Biology (162 citations). Shuli Tang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yanqiao Zhang, Jianan Cheng, Xiaoyi Huang, Changjie Lou, Liang Wang, Yuanlong Gu, Yuanfei Yao, Jie Lian, Haibo Lu and Qijia Xuan. Their work appears in journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026